January 10, 2018 / 7:43 AM / 14 days ago

BRIEF-Intervacc: Progress In Development Of New Vaccine Against Staphylococcus Aureus Infections

Jan 10 (Reuters) - INTERVACC AB:

* SIGNIFICANT PROGRESS HAS BEEN MADE IN THE DEVELOPMENT OF A NEW VACCINE AGAINST STAPHYLOCOCCUS AUREUS INFECTIONS

* ‍COSTS RELATED TO MASTITIS ARE ESTIMATED ANNUALLY ABOUT 200 MSEK ONLY IN SWEDEN AND IN US ABOUT 4500 MSEK​

* SAYS ‍NEED FOR A VACCINE TO COMPLEMENT OTHER PREVENTIVE MEASURES IS VERY LARGE​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below